Crown Pharm Co., Ltd. announced a private placement of 45,455 common shares at an issue price of KRW 22,000 per share for gross proceeds of KRW 1,000,010,000 on December 17, 2018. The transaction will involve participation from returning investor GL Pharm Tech Corp. (KOSDAQ:A204840). The shares were issued at a premium. The company will issue 0.089 new shares per 1 existing share. Post the closing of the transaction, the shares issued by the company will increase from 510,605 to 556,060. The transaction was approved by the board of directors of the company.